{"vid":"V975","name":"totalscore","file_id":"F1","var_intrvl":"discrete","var_width":"2","var_respunit":"Patients with type 2 diabetes being interviewed.","var_qstn_preqtxt":"SECTION 8 Anxiety and Quality of life\nGeneral anxiety- GAD-7 assessment\nOver the last two weeks, how often have you been bothered by the following problems","var_qstn_qstnlit":"Total score","var_qstn_postqtxt":"N\/A","var_qstn_ivulnstr":"N\/A","var_universe":"Patients with type 2 diabetes","universe_clusion":"I","var_sumstat":[{"value":"500","type":"vald"},{"value":"0","type":"invd"}],"var_txt":"N\/A","var_catgry":[{"value":"0","labl":null,"stats":"83","type":"freq"},{"value":"1","labl":null,"stats":"44","type":"freq"},{"value":"10","labl":null,"stats":"11","type":"freq"},{"value":"11","labl":null,"stats":"19","type":"freq"},{"value":"12","labl":null,"stats":"12","type":"freq"},{"value":"13","labl":null,"stats":"12","type":"freq"},{"value":"14","labl":null,"stats":"3","type":"freq"},{"value":"15","labl":null,"stats":"4","type":"freq"},{"value":"16","labl":null,"stats":"3","type":"freq"},{"value":"17","labl":null,"stats":"1","type":"freq"},{"value":"18","labl":null,"stats":"2","type":"freq"},{"value":"2","labl":null,"stats":"55","type":"freq"},{"value":"20","labl":null,"stats":"1","type":"freq"},{"value":"3","labl":null,"stats":"37","type":"freq"},{"value":"4","labl":null,"stats":"43","type":"freq"},{"value":"5","labl":null,"stats":"41","type":"freq"},{"value":"6","labl":null,"stats":"33","type":"freq"},{"value":"7","labl":null,"stats":"47","type":"freq"},{"value":"8","labl":null,"stats":"31","type":"freq"},{"value":"9","labl":null,"stats":"18","type":"freq"}],"var_format":"character","var_format_schema":"other","fid":"F1","sid":"175","survey_idno":"DDI-KEN-APHRC-GEGO-2021-v1.0"}